ライフサイエンスコーパス: activated factor VII

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ies for off-label utilization of recombinant activated factor VII.

2 Measured were plasma activated factor VII activity (FVIIa), FVII coagulant (F

3 for hemorrhage control, such as recombinant activated factor VII and hemostatic bandages, are in dev

4 binding constants of prothrombin, factor X, activated factor VII, and activated protein C to seven d

5 s (e.g., fresh-frozen plasma and recombinant-activated factor VII) are poorly aligned with recommende

6 drotrecogin alpha (activated protein C) and activated factor VII concentrate (NovoSeven), have been

7 In a recent phase II trial, recombinant activated factor VII (eptacog alfa) reduced haematoma ex

8 ne whether these associations are related to activated factor VII (factor VIIa).

9 TF monoclonal antibody and activated factor VII (FVIIa) binding studies showed that

10 Intravenous infusion of recombinant human activated Factor VII (FVIIa) has been used for over a de

11 Continuous expression of activated factor VII (FVIIa) via gene transfer is a pote

12 Catalytic domain variants of activated factor VII (FVIIa) with enhanced hemostatic pr

13 Successful competition of activated factor VII (FVIIa) with zymogen factor VII (FV

14 Recombinant activated factor VII has expanded available therapeutic

15 arize the safety and efficacy of recombinant activated factor VII in diverse clinical settings based

16 zed control trials investigating recombinant activated factor VII in non-hemophiliacs have been publi

17 Case reports would suggest that recombinant activated factor VII is an efficacious and safe "univers

18 Activated factor VII is approved for treating hemophilia

19 Recombinant activated factor VII is increasingly being used for off-

20 tion of thrombin generation with recombinant activated factor VII or activated prothrombin complex co

21 with soluble tissue factor and phospholipid, activated factor VII-Q10E32 displayed increased activati

22 trials have reported the use of recombinant-activated factor VII (rFVIIa) as an adjunct for reversal

23 Evidence suggests that recombinant activated factor VII (rFVIIa) can decrease intractable b

24 We sought to determine whether recombinant activated factor VII (rFVIIa) can reduce hematoma growth

25 Recombinant activated factor VII (rFVIIa) is a non-plasma-derived, r

26 onfirm a previous study in which recombinant activated factor VII (rFVIIa) reduced growth of the hema

27 alysis of safety and efficacy of recombinant activated factor VII (rFVIIa) used as the last resort fo

28 arrived the antihemophilic agent recombinant activated factor VII (rFVIIa).

29 blished as abstracts, supporting recombinant activated factor VII safety, but not its efficacy.

30 Activated factor VII (VIIa) was measured in 829 men.

31 ctivity of recombinant human TF complexed to activated factor VII was inhibited by PAEC and HAEC-asso

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。